Tempus AI Stock Rises on Strong Q2 Earnings and Raised Guidance
Tempus AI shares surged 3.6% on Friday, clawing back from an earlier 11.9% gain, after the healthcare AI company reported better-than-expected Q2 results. Revenue jumped 90% year-over-year to $314.6 million, crushing Wall Street's $297.8 million estimate. The genomics segment drove explosive growth.
The company narrowed its adjusted loss to $0.22 per share versus the anticipated $0.25 loss. Management raised full-year revenue guidance to $1.26 billion, signaling continued momentum in AI-driven healthcare analytics.